SCHEMBL6985392

SCHEMBL6985392

COc1ccc2nccc(C(CO)N3CCNCC3)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.58
CYP2D6 P10635 9/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 5/20 0.46
HSD17B10 Q99714 5/20 0.46
SLC6A4 P31645 5/20 0.46
ADRA2A P08913 4/20 0.46
OPRM1 P35372 4/20 0.46
KCNH2 Q12809 4/20 0.46
HPGD P15428 3/20 0.46
CYP3A4 P08684 3/20 0.46
TSHR P16473 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SLC6A3 Q01959 2/20 0.46
CHRM2 P08172 1/20 0.46
SLC22A1 O15245 3/20 0.43
ABCB11 O95342 3/20 0.43
ABCB1 P08183 3/20 0.43
SCN1A P35498 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7017484 0.85 CYP2D6 (0.48) CYP2D6KDM4EALDH1A1HSD17B10SLC6A4
SCHEMBL6988402 0.81 CYP2D6 (0.44) NCF1CYP2D6KDM4EALDH1A1HSD17B10
SCHEMBL6484668 0.80 NCF1 (0.58) NCF1CYP2D6KDM4EALDH1A1HSD17B10
SCHEMBL5757621 0.80 NCF1 (0.58) NCF1CYP2D6KDM4EALDH1A1HSD17B10
SCHEMBL6484670 0.80 NCF1 (0.58) NCF1CYP2D6KDM4EALDH1A1HSD17B10
SCHEMBL5648287 0.78 CYP2D6 (0.47) CYP2D6KDM4EALDH1A1HSD17B10SLC6A4
SCHEMBL6646680 0.78 CYP2D6 (0.47) CYP2D6KDM4EALDH1A1HSD17B10SLC6A4
SCHEMBL6985890 0.78 CCR8 (0.49) KDM4EALDH1A1KCNH2HTR1A
SCHEMBL6636311 0.73 NCF1 (1.00) NCF1HSD17B10CYP3A4HTR1A
SCHEMBL6971430 0.73 NCF1 (0.49) NCF1CYP2D6KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343780-A1 PIPERAZINE DERIVATIVES FOR TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM PLC (GB) 2003-09-17 EP disclosed
EP-1343765-A1 QUINOLINES AND NITROGENATED DERIVATIVES THEREOF SUBSTITUTED IN 4-POSITION BY A PIPERAZINE-CONTAINING MOIETY AND THEIR USE AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2003-09-17 EP disclosed
WO-2002050061-A1 PIPERAZINE DERIVATIVES FOR TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM P.L.C. (GB) 2002-06-27 WO disclosed
WO-2002050040-A1 QUINOLINES AND NITROGENATED DERIVATIVES THEREOF SUBSTITUTED IN 4-POSITION BY A PIPERAZINE-CONTAINING MOIETY AND THEIR USE AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2002-06-27 WO disclosed